Related Experiment Video
Updated: Mar 19, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Anger Traits Associated With Cardiovascular Risk Biomarkers in the Metabolic Syndrome
Alexandra V Lemche1, Oleg S Chaban, Erwin Lemche
1Alexandra V. Lemche, MD Researcher, Department of Psychosomatic Medicine, Charité-University Medicine, Berlin, Germany.Oleg S. Chaban, MD, PhD, DSc Full Professor, Section of Neuroses and Somatoform Disorders, Bogomolets National Medical University, Kiev, Ukraine.Erwin Lemche, PhD Senior Researcher, Section of Cognitive Neuropsychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College, London, United Kingdom.
Anger traits are linked to cardiovascular disease (CVD) biomarkers. Overt anger relates to lipid/obesity profiles, while covert hostility links to cholesterol profiles in metabolic syndrome patients.
Area of Science:
- Cardiology
- Psychology
- Metabolic Health
Background:
- Personality traits influence cardiovascular disease (CVD) mortality.
- Anger traits are associated with metabolic syndrome (MetS), a risk factor for CVD.
Purpose of the Study:
- To investigate the relationship between anger traits and CVD biomarkers.
- To examine how overt aggressivity and covert hostility correlate with MetS components.
Main Methods:
- 101 patients with MetS in Ukraine were analyzed.
- Regression models and structural equation models (SEMs) were used.
- Buss-Durkee Hostility Inventory assessed anger traits; MetS components were laboratory data.
Main Results:
- SEM revealed two distinct CVD biomarker profiles.
- One profile associated with overt anger (lipid/obesity measures).
- The other profile associated with covert hostility (cholesterol measures).
Conclusions:
- CVD risk biomarkers in MetS patients form two distinct profiles.
- These profiles correlate with overt anger and covert hostility.
- Findings may aid personalized CVD prevention and care.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures